Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Background Antimicrobial resistance (AMR) is an escalating global health crisis being worsened by climate change. Studies of ...
Lu]Lu-edotreotide led to statistically significant and clinically meaningful improvements in progression-free survival.